Tender Offer

A tender offer is a public or private invitation extended by a company or external buyer to shareholders, offering to purchase their shares at a predetermined price within a fixed deadline. The bidder may aim to acquire the entire company, repurchase its own shares, or consolidate control, and shareholders can choose whether to accept or hold.

The legal framework and mechanics

A tender offer is formalised through a detailed offer document that discloses the bidder’s identity, financing source, proposed price, conditions (such as minimum acceptance levels), and a fixed expiration date. Shareholders who wish to tender their shares deposit them with a depositary agent, which tallies votes and determines whether closing conditions are met.

The bidder must file a Schedule TO with the SEC (in the US), which triggers public disclosure. The target company is then required to file a Schedule 14D with its own recommendation (accept, reject, or remain neutral). This disclosure regime ensures shareholders have adequate information to decide whether to tender, and it creates an implicit cooling-off period during which shareholders can change their minds.

In friendly deals, negotiated in advance, the target board endorses the offer and publicly recommends shareholders accept. In hostile offers, the board opposes the bid and urges shareholders to reject it, often deploying defences like a poison-pill (shareholder rights plan) that dilutes the bidder’s stake or triggers redemption rights that hurt acquisition economics.

Two-tier and conditional structures

A classic two-tier tender offer works like this: the bidder offers USD 25 per share in cash for the first 50.1% tendered (the front-end), then proposes a lesser value (such as stock or preferred shares) for the remaining minority stake (the back-end). The asymmetry pressures shareholders to tender early, fearing they’ll be left holding lower-value back-end securities.

Two-tier offers are now rare and heavily regulated—many shareholders and regulators see them as coercive. Modern offers typically promise a single price for all shares tendered, reducing the coercion angle but requiring stronger financing certainty and a higher minimum acceptance threshold.

Conditional offers allow the bidder to walk away if too few shareholders tender, a deal-financing contingency falls through, or a material adverse change occurs. The target’s board typically negotiates a reverse termination fee if the bidder abandons the deal, aligning incentives. A non-conditional offer signals confidence but exposes the bidder to completion risk.

Friendly vs. hostile

Friendly tender offers are negotiated directly between the bidder and the target’s board. The board agrees in advance, usually receives a fairness opinion from an investment banker, and recommends shareholders accept. These deals move faster and face lower legal risk—the target does not deploy defensive tactics, and the bidder can rely on board co-operation for information and transitional advice.

Hostile tender offers are initiated without board consent and over board objection. The bidder appeals directly to shareholders, often via public advertisement and proxy solicitation. The target’s board opposes the bid, urges shareholders to reject, and may deploy defensive measures such as a poison-pill that grants existing shareholders the right to buy heavily discounted stock if the bidder crosses a threshold (often 15–20%). Other defences include golden parachutes for executives, white-knight recruitment of a preferred bidder, or a reverse merger with a chosen partner.

Successful hostile bids are rarer than friendly ones, especially in large-cap companies with sophisticated defences. But they do occur, particularly when a company’s stock price is depressed, the board appears passive or entrapped, and the bidder offers a substantial premium and credible financing.

Self-tenders and share repurchases

A company can conduct its own tender offer to repurchase shares from shareholders. This is a capital return mechanism, shrinking shares outstanding and potentially increasing earnings per share if the company buys back shares cheaper than the earnings yield justifies. A self-tender is often a signal that management believes the stock is undervalued.

Unlike open-market repurchases (which are ongoing and discretionary), a self-tender is a formal event with a defined price and deadline. It offers shareholders a choice: accept the offered price and sell, or hold. Shareholders who tender at, say, USD 30 per share are betting that the stock won’t rally further; those who hold are betting it will. Self-tenders can be oversubscribed (far more shares offered than the company wishes to buy), in which case the company buys pro-rata from all tenders.

Real-world dynamics and timing

Tender offer success hinges on several factors: the offer price relative to current trading price (typically 25–50% premium in acquisitions), the perceived strength of deal financing, the target’s strategic fit and growth prospects, shareholder sentiment, and the time allotted. A tight deadline (20 days) pressures shareholders to decide fast; a longer offer (60 days) gives them more time to seek alternative bids or challenge the deal in court.

Activist investors sometimes use tender offers as a negotiating tactic—bidding for control to force the target into a change-of-control sale at a higher price or to install their own board. Private equity bidders use them to consolidate control before taking a company private, often following a leveraged-buyout structure. Strategic acquirers use them to expand market share, consolidate supply chains, or eliminate competition.

Tax and accounting treatment

A shareholder who tenders shares in a cash tender offer recognizes a taxable gain equal to the tender price minus cost basis. The tax is due in the year of tender, and the holding period matters for capital gains classification. A stock-for-stock tender (where shareholders receive acquirer shares instead of cash) may qualify for tax-free exchange treatment under certain conditions, provided the deal meets reorganization criteria.

For the acquiring company, the purchase is accounted for at fair value of the shares acquired. If the price paid exceeds the book value of acquired assets, the excess is recorded as goodwill, which is tested for impairment annually.

See also